BP Stock News

AstraZeneca 's experimental drug baxdrostat has been successful in lowering high blood pressure in a late-stage study of people whose condition was hard to control or treat, the Anglo-Swedish drugmaker said on Monday, sending shares up 2%.

U.S.-listed shares of BP (BP) rose Friday after the energy giant predicted increased oil production and trading revenue in the current quarter, helping to offset lower fuel prices.

BP PLC (LSE:BP.) shares rose 2% in afternoon trading after the energy group indicated that its second-quarter numbers and outlook were less bleak than many had feared, despite continued underperformance.

There were also bright spots in the statement, which comes ahead of official second-quarter earnings on Aug. 5.

BP PLC (LSE:BP.) guided to higher upstream output and stronger refining margins in the second quarter trading update, offset by lower prices received for oil and gas.

BP's second-quarter results will be hit by lower prices it received for its gas and oil, it said in a quarterly trading update on Friday, ahead of full results due August 5.

Japan's Omron is planning to boost its presence in the Indian market, its CEO said on Thursday, as a surge in hypertension cases in the country is expected to create a large market for its blood pressure monitoring devices.

The Dividend Harvesting Portfolio hit new all-time highs in value, profitability, and forward income, with a 29.58% return on invested capital. Consistent weekly investing, diversification, and a focus on income-producing assets have driven strong performance, even through volatile markets and macroeconomic headwinds. I see significant opportunities ahead, especially for big tech, REITs, and en...